Thomas C. Hutton - 14 Feb 2025 Form 4 Insider Report for CHEMED CORP (CHE)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
18 Feb 2025, 16:03:02 UTC
Prior SEC filing
23 Oct 2024
Next SEC filing
22 Oct 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Thomas C. Hutton

Key filing fact

Thomas C. Hutton filed Form 4 for CHEMED CORP (CHE) on 18 Feb 2025.

Key facts

  • This page summarizes Thomas C. Hutton's Form 4 filing for CHEMED CORP (CHE).
  • 6 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 18 Feb 2025, 16:03.

Change

  • Previous filing in this sequence was filed on 23 Oct 2024.
  • Current net transaction value: +$144,988.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CHE transaction

Capital Stock

Options Exercise

Transaction value
$174,318
Shares
+315
Change %
+0.96%
Price
$553.39
Shares after
33,080
Date
14 Feb 2025
Ownership
Direct
Footnotes
F1
CHE transaction

Capital Stock

Options Exercise

Transaction value
$53,125
Shares
+96
Change %
+0.29%
Price
$553.39
Shares after
33,176
Date
14 Feb 2025
Ownership
Direct
Footnotes
F2
CHE transaction

Capital Stock

Tax liability

Transaction value
$82,455
Shares
-149
Change %
-0.45%
Price
$553.39
Shares after
33,027
Date
14 Feb 2025
Ownership
Direct
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CHE transaction Derivative

Performance Stock Units

Options Exercise

Transaction value
$0
Shares
-156
Change %
-17%
Price
$0.000000
Shares after
770
Date
14 Feb 2025
Ownership
Direct
Underlying class
Capital Stock
Underlying amount
156
Exercise price
Footnotes
F4, F5
CHE transaction Derivative

Performance Stock Units

Options Exercise

Transaction value
$0
Shares
-156
Change %
-20%
Price
$0.000000
Shares after
614
Date
14 Feb 2025
Ownership
Direct
Underlying class
Capital Stock
Underlying amount
156
Exercise price
Footnotes
F4, F5
CHE transaction Derivative

Performance Stock Units

Award

Transaction value
$0
Shares
+320
Change %
+52%
Price
$0.000000
Shares after
934
Date
14 Feb 2025
Ownership
Direct
Underlying class
Capital Stock
Underlying amount
320
Exercise price
Footnotes
F6, F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

The number of performace stock units ("PSUs") that vested was based on the Company's cumulative adjusted earnings per share for the period January 1, 2022 through December 31, 2024. The actual performance of $64.97 exceeded the maximum payout threshold of $63.75 and therefore yielded an award of 200% of target; including the reinvestment of dividends paid during such period, the award is 202.0% of target.

Footnote F2

The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2022 through December 31, 2024, compared to a defined peer group of companies. The Company's performance ranked in the 31.3 percentile of that group, yielding an award of 60.4%; including the reinvestment of dividends paid during such period, the award is 61.0% of target.

Footnote F3

Shares withheld to satisfy tax obligations in connection with vesting of PSUs.

Footnote F4

Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee.

Footnote F5

PSUs awarded February 18, 2022 vest based on achievement of performance targets over a period of January 1, 2022 to December 31, 2024. The determination of the performance level is to be made by March 15, 2025.

Footnote F6

Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock

Footnote F7

Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2025 to December 31, 2027. The determination of the performance level is to be made by March 15, 2028 and earned shares to be delivered thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .